FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yasuo Imanishi

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Yosuke Wakita; Shinsuke Yamada; Koichiro Yoda; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Toshiki Nagasaki; Yuki Nagata; Masaaki Inaba
Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto's thyroiditis.
Koichiro Yoda; Maki Yoda; Takashi Mishima; Katsuhito Mori; Shinsuke Yamada; Masanori Emoto; Mitsuru Ichii; Yasuo Imanishi; Masaaki Inaba
Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yasuo Imanishi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Cytokine 2013;61(3):912-6.
2013: Yosuke Wakita; Shinsuke Yamada; Koichiro Yoda; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Toshiki Nagasaki; Yuki Nagata; Masaaki Inaba
Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto's thyroiditis.
Thyroid research 2013;6(1):5.
2012: Koichiro Yoda; Maki Yoda; Takashi Mishima; Katsuhito Mori; Shinsuke Yamada; Masanori Emoto; Mitsuru Ichii; Yasuo Imanishi; Masaaki Inaba
Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.
The Journal of clinical endocrinology and metabolism 2012;97(11):E2036-43.
2012: Akira Ishii; Yasuo Imanishi
[Magnesium disorder in metabolic bone diseases].
Clinical calcium 2012;22(8):1251-6.
2012: Yasuo Imanishi
[Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
Clinical calcium 2012;22(7):1025-33.
2012: Maki Yoda; Yasuo Imanishi; Masaaki Inaba; Eiji Ishimura; Katsuhito Mori; Senji Okuno; Tetsuo Shoji; Shinsuke Yamada; Tomoyuki Yamakawa; Koichiro Yoda; Shigeichi Shoji
Poor muscle quality as a predictor of high mortality independent of diabetes in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(4):266-70.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Yasuo Imanishi; Yuki Nagata; Masaaki Inaba
Parathyroid diseases and animal models.
Frontiers in endocrinology 2012;3():78.
2012: Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Journal of bone and mineral metabolism 2012;30(1):93-9.
2011: Yuki Nagata; Hiroshi Naka; Masanori Emoto; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Takami Miki; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Masaaki Inaba
Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Endocrine 2011;40(2):315-7.
2011: Yasuo Imanishi; Andrew Arnold; Takehisa Kawata; Takao Kenko; Takami Miki; Nobuo Nagano; Michihito Wada; Masaaki Inaba
Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
Calcified tissue international 2011;89(1):29-35.
2011: M Kurajoh; Masaaki Inaba; Senji Okuno; H Nagayama; Shinsuke Yamada; Yasuo Imanishi; Eiji Ishimura; S Shoji; Tomoyuki Yamakawa; Yoshiki Nishizawa
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(3):923-30.
2010: Masaaki Inaba; M Kurajoh; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Katsuhito Mori; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus.
Clinical nephrology 2010;74(4):266-72.
2010: Akira Ishii; Yasuo Imanishi; Keisuke Kobayashi; Jun Hashimoto; Takafumi Ueda; Akimitsu Miyauchi; Hajime M Koyano; Hiroshi Kaji; Takatoshi Saito; Koichi Oba; Yasato Komatsu; Masafumi Kurajoh; Yuki Nagata; Hitoshi Goto; Kenichi Wakasa; Toshitsugu Sugimoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
Calcified tissue international 2010;86(6):455-62.
2010: Shinsuke Yamada; Masaaki Inaba; Shigeki Okada; Yasuo Imanishi; Katsuhito Mori; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(3):390-4.
2010: Akihiro Tamori; Masaru Enomoto; S Kobayashi; Shuji Iwai; H Morikawa; Hiroki Sakaguchi; Daiki Habu; Susumu Shiomi; Yasuo Imanishi; Norifumi Kawada
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
Journal of viral hepatitis 2010;17(2):123-9.
2010: Akira Ishii; Yasuo Imanishi; Masafumi Kurajoh; Yuki Nagata; Keisuke Kobayashi; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.
Endocrine journal 2010;57(7):609-14.
2009: Yasuo Imanishi; Masaaki Inaba; Takehisa Kawata; Yoshiki Nishizawa
Cinacalcet in hyperfunctioning parathyroid diseases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13 Suppl 1():S7-S11.
2009: Yasuo Imanishi; Masaaki Inaba; Takehisa Kawata; Yoshiki Nishizawa
Animal models of hyperfunctioning parathyroid diseases for drug development.
Expert opinion on drug discovery 2009;4(7):727-40.
2009: Yasuo Imanishi
[Clinical aspect of recent progress in phosphate metabolism. Phosphate retension, a powerful risk factor for mortality in chronic kidney disease (CKD)].
Clinical calcium 2009;19(6):828-35.
2008: Shinsuke Yamada; Masaaki Inaba; Masafumi Kurajoh; Kaori Shidara; Yasuo Imanishi; Eiji Ishimura; Yoshiki Nishizawa
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Clinical endocrinology 2008;69(2):189-96.
2008: M Kurajoh; Masaaki Inaba; Shinsuke Yamada; Yasuo Imanishi; Takao Tsuchida; Eiji Ishimura; Yoshiki Nishizawa
Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(5):709-16.
2008: Kaori Shidara; Masaaki Inaba; Senji Okuno; Shinsuke Yamada; Yasuro Kumeda; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Calcified tissue international 2008;82(4):278-87.
2007: Yasuo Imanishi
[Parathyroid and bone. Indication for parathyroidectomy in primary hyperparathyroidisms].
Clinical calcium 2007;17(12):1895-900.
2007: Yasuo Imanishi; Yoshiki Nishizawa
[Biochemical markers of bone turnover: Serum P1NP].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 9():231-5.
2007: Yasuo Imanishi; Keisuke Kobayashi; Takehisa Kawata; Masaaki Inaba; Yoshiki Nishizawa
Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2007;11 Suppl 1():S32-7.
2007: Yasuo Imanishi
[Renal osteodystrophy].
Clinical calcium 2007;17(10):1521-8.
2007: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
Journal of the American Society of Nephrology : JASN 2007;18(10):2683-8.
2007: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Yoko Fujino; Kaori Kohno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(3):417-25.
2007: Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Journal of the American Society of Nephrology : JASN 2007;18(3):896-903.
2007: Masaaki Inaba; Kazumasa Tanaka; Hitoshi Goto; Shinrei Sakai; Shinsuke Yamada; Hiroshi Naka; Yasuo Imanishi; Yoshiki Nishizawa
Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis.
The Journal of rheumatology 2007;34(2):290-5.
2007: Kaori Shidara; Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yasuro Kumeda; Yoshiki Nishizawa
Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(2-3):142-7.
2007: Naoko Obatake; Eiji Ishimura; Takao Tsuchida; Kaname Hirowatari; Hiroshi Naka; Yasuo Imanishi; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D.
Journal of bone and mineral metabolism 2007;25(1):74-9.
2006: Yasuo Imanishi; Yoshiki Nishizawa
[Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
Clinical calcium 2006;16(11):1844-50.
2006: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Atsushi Shioi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(10):1506-13.
2006: Shinsuke Yamada; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata-Sakurai; Yasuro Kumeda; Yasuo Imanishi; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Associations between physical activity, peripheral atherosclerosis and bone status in healthy Japanese women.
Atherosclerosis 2006;188(1):196-202.
2006: Yasuo Imanishi; Masaaki Inaba
[Secondary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 2():31-6.
2006: Yasuo Imanishi
[Primary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 2():5-9.
2006: Keisuke Kobayashi; Yasuo Imanishi
[Bone and bone related biochemical examinations. Hormone and hormone related substances. The measurement of circulating fibroblast growth factor 23 (FGF-23)].
Clinical calcium 2006;16(6):935-39.
2006: Keisuke Kobayashi; Yasuo Imanishi; Hiroyuki Koshiyama; Akimitsu Miyauchi; Kenichi Wakasa; Takehisa Kawata; Hitoshi Goto; Hirotsugu Ohashi; Hajime M Koyano; Ryuichi Mochizuki; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Life sciences 2006;78(20):2295-301.
2006: Masaaki Inaba; Senji Okuno; Hidenori Chou; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(2):62-5.
2006: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Senji Okuno; Yoshiaki Takemoto; Takeshi Komo; Hideki Tahara; Michihito Wada; Nobuo Nagano; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Journal of bone and mineral metabolism 2006;24(4):300-6.
2006: Keisuke Kobayashi; Yasuo Imanishi; Akimitsu Miyauchi; Naoyoshi Onoda; Takehisa Kawata; Hideki Tahara; Hitoshi Goto; Takami Miki; Eiji Ishimura; Toshitsugu Sugimoto; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(1):93-9.
2006: Takao Tsuchida; Eiji Ishimura; Kaname Hirowatari; Naoki Matsumoto; Yasuo Imanishi; Shuichi Jono; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
Nephron. Clinical practice 2006;102(3-4):c108-14.
2005: Hideki Ueda; Eiji Ishimura; Takayuki Yunoki; Takao Tsuchida; Naoki Matsumoto; Syuichi Jono; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.
Clinical and experimental nephrology 2005;9(4):332-4.
2005: Yasuo Imanishi; Keisuke Kobayashi
[FGF-23 in primary and secondary hyperparathyroidisms].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():539-44.
2005: Yasuo Imanishi
[Regulation of fibroblast growth factor 23 in metabolic bone diseases].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():486-91.
2005: Yoshiki Nishizawa; Yasuo Imanishi
[Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():469-74.
2005: Yasuo Imanishi; Takehisa Kawata
[Experimental animal models of primary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():292-9.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takao Kenko; Michihito Wada; Eiji Ishimura; Takami Miki; Nobuo Nagano; Masaaki Inaba; Andrew Arnold; Yoshiki Nishizawa
Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(4):587-94.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Yoshiaki Takemoto; Hideki Tahara; Senji Okuno; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
The Journal of clinical endocrinology and metabolism 2005;90(10):5774-8.
2005: Yasuo Imanishi; Takehisa Kawata; Keisuke Kobayashi; Masaaki Inaba; Yoshiki Nishizawa; Jun Shioi; Takami Miki
[Vascular calcification in advanced secondary hyperparathyroidism].
Clinical calcium 2005;15 Suppl 1():110-2; discussion 112.
2005: Kaori Shidara; Masaaki Inaba; Yasuro Kumeda; Yasuo Imanishi; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
Clinical calcium 2005;15 Suppl 1():102-4; discussion 104-5.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa; Yoshiaki Takemoto; Naoyoshi Onoda; Senji Okuno; Tetsuro Ishikawa
[Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
Clinical calcium 2005;15 Suppl 1():98-100; discussion 100-1.
2005: Masaaki Inaba; Yasuo Imanishi; Misako Ueda; Hidenori Cho; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Clinical calcium 2005;15 Suppl 1():64-6; discussion 66-7.
2005: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):517-25.
2005: Misako Ueda; Masaaki Inaba; Hideki Tahara; Yasuo Imanishi; Hitoshi Goto; Yoshiki Nishizawa
Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia.
Internal medicine (Tokyo, Japan) 2005;44(4):307-10.
2005: Yasuo Imanishi; Yoshiki Nishizawa
[Strontium Ranelate as a new therapeutic agent for osteoporosis].
Clinical calcium 2005;15(1):25-8.
2004: Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2004: Yasuo Imanishi; Yoshiki Nishizawa
[The effect of lifestyle factors on osteoporotic fractures].
Clinical calcium 2004;14(2):298-301.
2004: Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.
Clinical chemistry 2004;50(2):385-90.
2004: Takami Miki; Kiyoshi Nakatsuka; Hiroshi Naka; Hideki Masaki; Yasuo Imanishi; Masako Ito; Masaaki Inaba; Hirotoshi Morii; Yoshiki Nishizawa
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
Journal of bone and mineral metabolism 2004;22(6):569-76.
2003: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Naoki Matsumoto; Eiji Ishimura; Hidenori Koyama; Shinji Tanaka; Yasuo Imanishi; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Blocking of alpha 5 integrin stimulates production of TGF-beta and PAI-1 by human mesangial cells.
Biochemical and biophysical research communications 2003;305(4):815-9.
2003: Kyoko Nagasue; Masaaki Inaba; Senji Okuno; Kayoko Kitatani; Yasuo Imanishi; Eiji Ishimura; Takami Miki; Masao Kim; Yoshiki Nishizawa
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(2):98-104.
2003: Yoko Fujino; Masaaki Inaba; Kiyoshi Nakatsuka; Yasuro Kumeda; Yasuo Imanishi; Hideki Tahara; Takeo Goto; Yuichi Inoue; Tatsuya Nakatani; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Primary hyperparathyroidism with multiple osteosclerotic lesions of the calvarium.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(3):410-2.
2003: Yasuo Imanishi; Kiyoshi Nakatsuka; Tetsuo Nakayama; Terue Okamura; Keisuke Kobayashi; Keiko Nakayama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
False-positive magnetic resonance imaging skeletal survey in a patient with sporadic hypophosphatemic osteomalacia.
Journal of bone and mineral metabolism 2003;21(1):57-9.
2002: Yasuo Imanishi; Keisuke Kobayashi
[Pathogenesis of uremic secondary hyperparathyroidism].
Clinical calcium 2002;12(12):1645-9.
2002: Yoko Fujino; Masaaki Inaba; Yasuo Imanishi; Mayumi Nagata; Hitoshi Goto; Yasuro Kumeda; Tatsuya Nakatani; Eiji Ishimura; Yoshiki Nishizawa
A case of SIADH induced by mizoribin administration.
Nephron 2002;92(4):938-40.
2002: Yasuo Imanishi
[Phosphate kinetics in dialysis patients].
Clinical calcium 2002;12(10):1390-3.
2002: Masaaki Inaba; Kyoko Nagasue; Senji Okuno; Misako Ueda; Yasuro Kumeda; Yasuo Imanishi; Tetsuo Shoji; Eiji Ishimura; Tomohiro Ohta; Tatsuya Nakatani; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2002: Yasuo Imanishi
[FGF-23 on hypophosphatemic rickets/osteomalacia].
Clinical calcium 2002;12(5):634-7.
2002: Hideki Ueda; Eiji Isimura; Senji Okuno; Kiyoshi Maekawa; Tsuyoshi Izumotani; Masao Kim; Naoki Matsumoto; Shinya Fukumoto; Yasuo Imanishi; Masanori Emoto; Tetsuo Shoji; Hideki Wanibuchi; Masaaki Inaba; Yoshiki Nishizawa
[Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Nihon Jinzo Gakkai shi 2002;44(4):420-6.
2002: Yasuo Imanishi
Molecular pathogenesis of tumorigenesis in sporadic parathyroid adenomas.
Journal of bone and mineral metabolism 2002;20(4):190-5.
2001: Yasuo Imanishi
[Cyclin D1 in sporadic parathyroid adenomas].
Clinical calcium 2001;11(12):1637-41.
2001: Masaaki Inaba; Senji Okuno; Kyoko Nagasue; T Otoshi; Y Kurioka; Kiyoshi Maekawa; Yasuro Kumeda; Yasuo Imanishi; Eiji Ishimura; T Ohta; Hirotoshi Morii; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S139-42.
2001: M Waki; Masaaki Inaba; Yoshikazu Hiura; Toshiki Nagasaki; Yasuo Imanishi; Eiji Ishimura; Shuzo Otani; Yoshiki Nishizawa
Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Archives of biochemistry and biophysics 2001;391(2):265-70.
2000: Hideki Tahara; Yasuo Imanishi; T Yamada; Yoshihiro Tsujimoto; Tsutomu Tabata; Takashi Inoue; Masaaki Inaba; Hirotoshi Morii; Yoshiki Nishizawa
Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
The Journal of clinical endocrinology and metabolism 2000;85(11):4113-7.
2000: Masaaki Inaba; Tetsuro Ishikawa; Yasuo Imanishi; Eiji Ishimura; Kiyoshi Nakatsuka; Hirotoshi Morii; Yoshiki Nishizawa
Pathophysiology and diagnosis of primary hyperparathyroidism--strategy for asymptomatic primary hyperparathyroidism.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2000;54 Suppl 1():7s-11s.
2000: Yasuo Imanishi; Masaaki Inaba
[Autoimmune hypoparathyroidism].
Ryōikibetsu shōkōgun shirīzu 2000;(31):108-11.
1999: Yasuo Imanishi; Masaaki Inaba; H Seki; H Koyama; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
The Journal of steroid biochemistry and molecular biology 1999;70(4-6):243-8.